Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?

被引：0
|
作者：
Haass, Nikolas K. [1 ,2 ,3 ]
机构：
[1] Univ Queensland, Univ Queensland Diamantina Inst & Translat Res In, Brisbane, Qld, Australia
[2] Centenary Inst, Newtown, NSW, Australia
[3] Univ Sydney, Discipline Dermatol, Sydney, NSW 2006, Australia
来源：
MELANOMA MANAGEMENT | 2015年 / 2卷 / 02期
基金：
英国医学研究理事会;
关键词：
cancer drug resistance; fluorescent ubiquitination-based; cell cycle indicator; invasion; melanoma heterogeneity; migration; real-time imaging; tumor microenvironment;
D O I：
10.2217/MMT.15.1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 95
页数：3
相关论文
共 50 条
  • [41] When and How Do We Need Permission to Help Patients Address Social Risk?
    Devoe, Jennifer E.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (02) : 176 - 178
  • [42] How do we address the disconnect between genetic and morphological diversity in germplasm collections?
    Jansky, Shelley H.
    Dawson, Julie
    Spooner, David M.
    [J]. AMERICAN JOURNAL OF BOTANY, 2015, 102 (08) : 1213 - 1215
  • [43] How to make a melanoma: what do we know of the primary clonal events?
    Bennett, Dorothy C.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (01) : 27 - 38
  • [44] Malignant Melanoma: How Do We Meet the Needs of Young People and Their Families?
    McInally, Wendy
    [J]. COMPREHENSIVE CHILD AND ADOLESCENT NURSING-BUILDNG EVIDENCE FOR PRACTICE, 2018, 41 (01): : 5 - 8
  • [45] 'What is therapy's value, and how do we decide this?'
    Florance, Ian
    Rizq, Rosemary
    [J]. PSYCHOLOGIST, 2020, 33 : 56 - 59
  • [46] Combinatorial therapy in tumor microenvironment: Where do we stand?
    Kumari, Smita
    Advani, Dia
    Sharma, Sudhanshu
    Ambasta, Rashmi K.
    Kumar, Pravir
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [47] Speech therapy in the treatment of globus pharyngeus: how we do it
    Khalil, H. S.
    Reddy, V. M.
    Bos-Clark, M.
    Dowley, A.
    Pierce, M. H.
    Morris, C. P.
    Jones, A. E.
    [J]. CLINICAL OTOLARYNGOLOGY, 2011, 36 (04) : 388 - +
  • [48] Therapy for osteoarthritis in the horse - How do we know that it works?
    Clegg, PD
    [J]. VETERINARY JOURNAL, 2006, 171 (01): : 9 - 10
  • [49] How do we sequence therapy for marginal zone lymphomas?
    Broccoli, Alessandro
    Zinzani, Pier Luigi
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 295 - 305
  • [50] Time to reconsider how we do antibiotic therapy trials
    Welte, Tobias
    [J]. LANCET INFECTIOUS DISEASES, 2015, 15 (02): : 132 - 133
12345